Anti-apoA-1 autoantibodies increase mouse atherosclrotic plaque vulnerability, myocardial necrosis and mortality trough TLR2 and TLR4-mediated pathways. Issue 1 (July 2015) - Montecucco, F.; Braunersreuther, V.; Burger, F.; Lenglet, S.; Pelli, G.; Carbone, F.; Fraga-Silva, R.; Stergiopulos, N.; Monaco, C.; Mueller, C.; Pagano, S.; Dallegri, F.; et al.